Q1 2026 Pharma Video Ad Snapshot
Unified across creatives, audiences, and outcomes: showing what drove pharma video ad performance in Q1.
In Q1, pharma brands got more intentional—pairing clear, product-focused video creative with smarter cross-platform strategies.
As national linear spend and impressions climbed, performance hinged less on scale alone and more on how effectively brands reduced friction in their messaging and reached action-ready audiences across platforms. Streaming, in particular, surfaced strong conversion efficiency—highlighting where engagement translated into real response.
Our latest snapshot breaks it all down, including the creatives driving the strongest Likeability, top brands by streaming impression SOV, and the publishers delivering the highest web conversions. It’s a focused look at how pharma advertisers are aligning creatives, media, and outcomes to drive performance.
Q1 Pharma Insights Include:
- Creative: Top ads from Cologuard and Wegovy outperformed by +19% to +18% vs. Likeability norm, proving clarity beats complexity.
- Audience: Streaming SOV leaders like Skyrizi and Tremfya stay balanced with linear, while others leaned more heavily into streaming to extend reach.
- Outcome: Tubi led web conversion rates across a 7-day attribution window.